2024 Q3 Form 10-Q Financial Statement

#000079526624000119 Filed on October 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $1.753B
YoY Change 10.43%
Cost Of Revenue $1.386B
YoY Change 11.7%
Gross Profit $367.0M
YoY Change 5.9%
Gross Profit Margin 20.94%
Selling, General & Admin $173.1M
YoY Change 7.1%
% of Gross Profit 47.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.416M
YoY Change 2.35%
% of Gross Profit 2.57%
Operating Expenses $173.1M
YoY Change 7.1%
Operating Profit $194.0M
YoY Change 4.85%
Interest Expense $13.46M
YoY Change 41.66%
% of Operating Profit 6.94%
Other Income/Expense, Net
YoY Change
Pretax Income $207.4M
YoY Change 6.63%
Income Tax $50.10M
% Of Pretax Income 24.15%
Net Earnings $157.3M
YoY Change 4.93%
Net Earnings / Revenue 8.98%
Basic Earnings Per Share $2.10
Diluted Earnings Per Share $2.04
COMMON SHARES
Basic Shares Outstanding 74.48M shares
Diluted Shares Outstanding 76.63M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $375.7M
YoY Change -38.65%
Cash & Equivalents $375.7M
Short-Term Investments
Other Short-Term Assets $23.73M
YoY Change 6.42%
Inventory $5.649B
Prepaid Expenses
Receivables $180.5M
Other Receivables $193.0M
Total Short-Term Assets $6.422B
YoY Change 4.5%
LONG-TERM ASSETS
Property, Plant & Equipment $109.0M
YoY Change -2.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $82.73M
YoY Change 0.64%
Other Assets $113.8M
YoY Change -22.07%
Total Long-Term Assets $418.0M
YoY Change -3.11%
TOTAL ASSETS
Total Short-Term Assets $6.422B
Total Long-Term Assets $418.0M
Total Assets $6.840B
YoY Change 4.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $403.8M
YoY Change 3.17%
Accrued Expenses $648.1M
YoY Change 18.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.114B
YoY Change 9.29%
LONG-TERM LIABILITIES
Long-Term Debt $1.691B
YoY Change 0.06%
Other Long-Term Liabilities $48.00M
YoY Change 26.97%
Total Long-Term Liabilities $1.739B
YoY Change 0.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.114B
Total Long-Term Liabilities $1.739B
Total Liabilities $2.853B
YoY Change 3.85%
SHAREHOLDERS EQUITY
Retained Earnings $4.088B
YoY Change 15.42%
Common Stock $958.5M
YoY Change 1.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.987B
YoY Change
Total Liabilities & Shareholders Equity $6.840B
YoY Change 4.0%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $157.3M
YoY Change 4.93%
Depreciation, Depletion And Amortization $9.416M
YoY Change 2.35%
Cash From Operating Activities -$89.91M
YoY Change -154.89%
INVESTING ACTIVITIES
Capital Expenditures $9.474M
YoY Change 16.96%
Acquisitions
YoY Change
Other Investing Activities $318.0K
YoY Change -105.48%
Cash From Investing Activities -$9.156M
YoY Change -34.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -169.5M
YoY Change 78.22%
NET CHANGE
Cash From Operating Activities -89.91M
Cash From Investing Activities -9.156M
Cash From Financing Activities -169.5M
Net Change In Cash -268.6M
YoY Change -590.07%
FREE CASH FLOW
Cash From Operating Activities -$89.91M
Capital Expenditures $9.474M
Free Cash Flow -$99.39M
YoY Change -163.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
KB HOME
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-3666267
dei Entity Address Address Line1
EntityAddressAddressLine1
10990 Wilshire Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90024
dei City Area Code
CityAreaCode
310
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4736641000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
571675000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131800000 usd
us-gaap Net Income Loss
NetIncomeLoss
439875000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.18
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81790000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84332000 shares
CY2024Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2023Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.20
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
98000000 usd
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.70
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.70
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
603213000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50100000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138800000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
157329000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
149933000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.10
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5700000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-14900000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
23934000 usd
dei Local Phone Number
LocalPhoneNumber
231-4000
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
95715000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
93670000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
95715000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000795266
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 kbh Capitalized Interest Amortized To Land Costs
CapitalizedInterestAmortizedToLandCosts
200000 usd
kbh Capitalized Interest Amortized To Land Costs
CapitalizedInterestAmortizedToLandCosts
200000 usd
kbh Capitalized Interest Amortized To Land Costs
CapitalizedInterestAmortizedToLandCosts
200000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherAssets
CY2024Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrentAndNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrentAndNoncurrent
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
500000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
800000 usd
dei Security12b Title
Security12bTitle
Common Stock (par value $1.00 per share)
dei Trading Symbol
TradingSymbol
KBH
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73334477 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1752608000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1587011000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4930187000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
207429000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
194533000 usd
us-gaap Net Income Loss
NetIncomeLoss
464413000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.94
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74476000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80175000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75339000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76630000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82732000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77565000 shares
CY2024Q3 us-gaap Assets
Assets
6839880000 usd
CY2023Q4 us-gaap Assets
Assets
6648362000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101891905 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101275979 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
101892000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
101276000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
856603000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
845693000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4087800000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3676924000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3671000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3671000 usd
CY2024Q3 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
6705247 shares
CY2023Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
6705247 shares
CY2024Q3 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
72718000 usd
CY2023Q4 us-gaap Common Stock Issued Employee Stock Trust
CommonStockIssuedEmployeeStockTrust
72718000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
21852181 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
18703704 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
982812000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
737364000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3987094000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3810140000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6839880000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6648362000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3991704000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
157329000 usd
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18407000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7968000 usd
CY2024Q3 kbh Stock Repurchased During Period Including Excise Tax Value
StockRepurchasedDuringPeriodIncludingExciseTaxValue
151500000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3987094000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3766482000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
149933000 usd
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15928000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3598000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9248000 usd
CY2023Q3 kbh Stock Repurchased During Period Including Excise Tax Value
StockRepurchasedDuringPeriodIncludingExciseTaxValue
83205000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3830128000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3810140000 usd
us-gaap Net Income Loss
NetIncomeLoss
464413000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
53537000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9272000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25252000 usd
kbh Stock Repurchased During Period Including Excise Tax Value
StockRepurchasedDuringPeriodIncludingExciseTaxValue
251941000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
16505000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3987094000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3660795000 usd
us-gaap Net Income Loss
NetIncomeLoss
439875000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
41635000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8608000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23934000 usd
kbh Stock Repurchased During Period Including Excise Tax Value
StockRepurchasedDuringPeriodIncludingExciseTaxValue
251701000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9748000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3830128000 usd
us-gaap Net Income Loss
NetIncomeLoss
464413000 usd
us-gaap Net Income Loss
NetIncomeLoss
439875000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22654000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9975000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
21275000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
12172000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2602000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2525000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
28259000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
26986000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
12516000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
25252000 usd
kbh Inventory Impairments And Land Option Contract Abandonments
InventoryImpairmentsAndLandOptionContractAbandonments
3685000 usd
kbh Inventory Impairments And Land Option Contract Abandonments
InventoryImpairmentsAndLandOptionContractAbandonments
10207000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-6205000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
1581000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
504436000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-355280000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14405000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-100486000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3299000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1314000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
772523000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
12611000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
23461000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1992000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
5100000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
1709000 usd
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29228000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26412000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38138000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44773000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
170000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
320000000 usd
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-2822000 usd
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-3188000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9272000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8608000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
250000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
249588000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16505000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9748000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
53537000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
41635000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-313592000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-445551000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-351649000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
282199000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
727342000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
330198000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
375693000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
612397000 usd
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates. </span>The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
218900000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
508200000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
157300000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
149900000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
464400000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
439900000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5 segment
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
157329000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
149933000 usd
us-gaap Net Income Loss
NetIncomeLoss
464413000 usd
us-gaap Net Income Loss
NetIncomeLoss
439875000 usd
CY2024Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
143000 usd
CY2023Q3 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
120000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
406000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
295000 usd
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1062000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
998000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
3137000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2851000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
156124000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
148815000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
460870000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
436729000 usd
CY2024Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-1062000 usd
CY2023Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-998000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-3137000 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-2851000 usd
CY2024Q3 kbh Undistributed Earnings Reallocatedto Participating Securities
UndistributedEarningsReallocatedtoParticipatingSecurities
1032000 usd
CY2023Q3 kbh Undistributed Earnings Reallocatedto Participating Securities
UndistributedEarningsReallocatedtoParticipatingSecurities
967000 usd
kbh Undistributed Earnings Reallocatedto Participating Securities
UndistributedEarningsReallocatedtoParticipatingSecurities
3047000 usd
kbh Undistributed Earnings Reallocatedto Participating Securities
UndistributedEarningsReallocatedtoParticipatingSecurities
2766000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
156154000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
148846000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
460960000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
436814000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74476000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80175000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75339000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81790000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2154000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2557000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2226000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2542000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76630000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82732000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77565000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84332000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.10
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.34
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.94
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.18
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2024Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
10626000 usd
CY2023Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
0 usd
CY2024Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
2316960000 usd
CY2023Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
2106149000 usd
CY2024Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
3331970000 usd
CY2023Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
3027497000 usd
CY2024Q3 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
5648930000 usd
CY2023Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
5133646000 usd
CY2024Q3 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
10500000 usd
CY2023Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
17000000 usd
CY2024Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
131765000 usd
CY2023Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
141225000 usd
CY2023Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
134375000 usd
CY2022Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
145494000 usd
CY2024Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
26583000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
26810000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
79665000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
80609000 usd
CY2024Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
28180000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
29305000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
83872000 usd
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
87373000 usd
CY2024Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
130168000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
138730000 usd
CY2024Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
130168000 usd
CY2023Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
138730000 usd
CY2024Q3 kbh Capitalized Interest Amortized To Land Costs
CapitalizedInterestAmortizedToLandCosts
0 usd
CY2024Q3 kbh Number Of Active Land Parcels Or Communities Evaluated For Recoverability
NumberOfActiveLandParcelsOrCommunitiesEvaluatedForRecoverability
6 community
CY2024Q3 kbh Carrying Value Of Communities Or Land Parcels Evaluated For Impairment
CarryingValueOfCommunitiesOrLandParcelsEvaluatedForImpairment
121000000.0 usd
CY2023Q4 kbh Number Of Active Land Parcels Or Communities Evaluated For Recoverability
NumberOfActiveLandParcelsOrCommunitiesEvaluatedForRecoverability
5 community
CY2023Q4 kbh Carrying Value Of Communities Or Land Parcels Evaluated For Impairment
CarryingValueOfCommunitiesOrLandParcelsEvaluatedForImpairment
89300000 usd
CY2024Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2023Q3 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0 usd
CY2024Q3 kbh Aggregate Carrying Value Of Inventory Impacted By Pretax Noncash Inventory Impairment Charges
AggregateCarryingValueOfInventoryImpactedByPretaxNoncashInventoryImpairmentCharges
48400000 usd
CY2024Q3 kbh Number Of Communities And Various Other Land Parcels Impacted By Pretax Noncash Inventory Impairment Charges
NumberOfCommunitiesAndVariousOtherLandParcelsImpactedByPretaxNoncashInventoryImpairmentCharges
5 community
CY2023Q4 kbh Aggregate Carrying Value Of Inventory Impacted By Pretax Noncash Inventory Impairment Charges
AggregateCarryingValueOfInventoryImpactedByPretaxNoncashInventoryImpairmentCharges
73900000 usd
CY2023Q4 kbh Number Of Communities And Various Other Land Parcels Impacted By Pretax Noncash Inventory Impairment Charges
NumberOfCommunitiesAndVariousOtherLandParcelsImpactedByPretaxNoncashInventoryImpairmentCharges
5 community
CY2024Q3 kbh Cash Deposits On Land Option And Other Similar Contracts
CashDepositsOnLandOptionAndOtherSimilarContracts
77458000 usd
CY2024Q3 kbh Aggregate Purchase Price Associated With Land Option And Other Similar Contracts
AggregatePurchasePriceAssociatedWithLandOptionAndOtherSimilarContracts
2122073000 usd
CY2023Q4 kbh Cash Deposits On Land Option And Other Similar Contracts
CashDepositsOnLandOptionAndOtherSimilarContracts
45018000 usd
CY2023Q4 kbh Aggregate Purchase Price Associated With Land Option And Other Similar Contracts
AggregatePurchasePriceAssociatedWithLandOptionAndOtherSimilarContracts
1268532000 usd
CY2024Q3 kbh Acquisition Costs Related To Land Option Contracts And Other Similar Contracts
AcquisitionCostsRelatedToLandOptionContractsAndOtherSimilarContracts
26000000.0 usd
CY2023Q4 kbh Acquisition Costs Related To Land Option Contracts And Other Similar Contracts
AcquisitionCostsRelatedToLandOptionContractsAndOtherSimilarContracts
18500000 usd
CY2024Q3 kbh Increase In Inventories And Accrued Expenses And Other Liabilities Due To Land Option And Other Similar Contracts
IncreaseInInventoriesAndAccruedExpensesAndOtherLiabilitiesDueToLandOptionAndOtherSimilarContracts
26100000 usd
CY2023Q4 kbh Increase In Inventories And Accrued Expenses And Other Liabilities Due To Land Option And Other Similar Contracts
IncreaseInInventoriesAndAccruedExpensesAndOtherLiabilitiesDueToLandOptionAndOtherSimilarContracts
21500000 usd
CY2023Q4 kbh Number Of Investments In Unconsolidated Joint Ventures
NumberOfInvestmentsInUnconsolidatedJointVentures
6 joint_venture
CY2024Q3 kbh Number Of Investments In Unconsolidated Joint Ventures
NumberOfInvestmentsInUnconsolidatedJointVentures
6 joint_venture
CY2024Q3 kbh Number Of Unconsolidated Joint Ventures With Loan Commitments
NumberOfUnconsolidatedJointVenturesWithLoanCommitments
1 joint_venture
CY2023Q4 kbh Number Of Unconsolidated Joint Ventures With Loan Commitments
NumberOfUnconsolidatedJointVenturesWithLoanCommitments
1 joint_venture
CY2023Q4 kbh Number Of Other Unconsolidated Joint Ventures With Outstanding Debt
NumberOfOtherUnconsolidatedJointVenturesWithOutstandingDebt
0 joint_venture
CY2024Q3 kbh Number Of Other Unconsolidated Joint Ventures With Outstanding Debt
NumberOfOtherUnconsolidatedJointVenturesWithOutstandingDebt
0 joint_venture
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Rate Lock Commitments (“IRLCs”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. KBHS enters into IRLCs in connection with originating certain mortgage loans held for sale, at specified interest rates and within a specified period of time, with customers who have applied for a mortgage loan and meet certain credit and underwriting criteria. KBHS accounts for IRLCs as free-standing derivatives and does not designate any for hedge accounting. As a result, IRLCs are recognized in KBHS’ balance sheets at fair value, and gains or losses resulting from changes in fair value are recognized within revenues in KBHS’ statements of operations. The fair value of IRLCs is based on market prices, which includes an estimate of the fair value of the associated mortgage servicing rights, adjusted for estimated costs to originate the underlying mortgage loans as well as the probability that the mortgage loans will fund within the terms of the IRLCs. The fair value of IRLCs included in other assets in KBHS’ balance sheets was $17.6 million at August 31, 2024 and $13.9 million at November 30, 2023. The changes in the fair value of IRLCs, which were reported in revenues for the applicable periods, were a loss of $.4 million for the three months ended August 31, 2024, a gain of $3.8 million for the nine months ended August 31, 2024, and losses of $5.2 million and $9.4 million for the three-month and nine-month periods ended August 31, 2023, respectively. </span></div>KBHS manages the interest rate and price risk associated with its outstanding IRLCs by entering into best efforts forward sale commitments under which mortgage loans locked with a borrower are simultaneously committed to a secondary market investor at a fixed price, subject to the underlying mortgage loans being funded. These best efforts forward sale commitments do not meet the definition of derivative financial instruments and are therefore not recorded in KBHS’ balance sheets. If the mortgage loans underlying the IRLCs do not fund, KBHS has no obligation to fulfill the secondary market investor commitments.
CY2024Q1 us-gaap Equity Ownership Percentage Excluding Consolidated Entity And Equity Method Investee
EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
0.135
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
12500000 usd
CY2024Q3 kbh Self Insuranceand Other Legal Liabilities
SelfInsuranceandOtherLegalLiabilities
294274000 usd
CY2023Q4 kbh Self Insuranceand Other Legal Liabilities
SelfInsuranceandOtherLegalLiabilities
269735000 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
157722000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
171408000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
93670000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
56988000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
58910000 usd
CY2024Q3 kbh Inventoryrelatedliabilities
Inventoryrelatedliabilities
46360000 usd
CY2023Q4 kbh Inventoryrelatedliabilities
Inventoryrelatedliabilities
41525000 usd
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
17392000 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
29391000 usd
CY2024Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
16966000 usd
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
15169000 usd
CY2024Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
4842000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1851000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
47996000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
45707000 usd
CY2024Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
757928000 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
758227000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5100000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
5700000 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1900000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2400000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
15400000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
16500000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5600000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
6300000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19771000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
24773000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
21754000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
26581000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50100000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
44600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
138800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
131800000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.242
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.229
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.231
CY2024Q3 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
3900000 usd
CY2024Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2400000 usd
CY2023Q3 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
6900000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1900000 usd
CY2023Q3 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2600000 usd
us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
12800000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
6500000 usd
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
7900000 usd
us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
19400000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5700000 usd
us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
9200000 usd
CY2024Q3 kbh Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
130700000 usd
CY2023Q4 kbh Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
136400000 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16900000 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16900000 usd
kbh Valuation Allowance Deferred Tax Asset Increase Decrease Amount Other
ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAmountOther
0 usd
CY2024Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1691060000 usd
CY2023Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1689898000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
12100000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
13900000 usd
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-08-25
CY2024Q3 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
11700000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
360600000 usd
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
300800000 usd
CY2024Q3 kbh Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
1040000000.00 usd
kbh Structural Warranty Provided By Company
StructuralWarrantyProvidedByCompany
P10Y
kbh Warranty For Other Components Of Home
WarrantyForOtherComponentsOfHome
P1Y
CY2024Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
94803000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
99142000 usd
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
98000000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
101890000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
9731000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
9354000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
27596000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
27997000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10864000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
12781000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
31926000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
34172000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
93670000 usd
CY2024Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
173029000 usd
CY2023Q2 us-gaap Self Insurance Reserve
SelfInsuranceReserve
172223000 usd
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
179832000 usd
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
175977000 usd
CY2024Q3 kbh Expenses Associated With Self Insurance
ExpensesAssociatedWithSelfInsurance
5604000 usd
CY2023Q3 kbh Expenses Associated With Self Insurance
ExpensesAssociatedWithSelfInsurance
4794000 usd
kbh Expenses Associated With Self Insurance
ExpensesAssociatedWithSelfInsurance
14867000 usd
kbh Expenses Associated With Self Insurance
ExpensesAssociatedWithSelfInsurance
12612000 usd
CY2024Q3 kbh Paymentsfor Self Insurance
PaymentsforSelfInsurance
3206000 usd
CY2023Q3 kbh Paymentsfor Self Insurance
PaymentsforSelfInsurance
4277000 usd
kbh Paymentsfor Self Insurance
PaymentsforSelfInsurance
14686000 usd
kbh Paymentsfor Self Insurance
PaymentsforSelfInsurance
13411000 usd
CY2024Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
172017000 usd
CY2023Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
173999000 usd
CY2024Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
172017000 usd
CY2023Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
173999000 usd
CY2024Q3 kbh Performance Bonds
PerformanceBonds
1310000000 usd
CY2024Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
78900000 usd
CY2023Q4 kbh Performance Bonds
PerformanceBonds
1320000000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
19100000 usd
CY2024Q3 kbh Cash Deposits On Land Option And Other Similar Contracts
CashDepositsOnLandOptionAndOtherSimilarContracts
77500000 usd
CY2024Q3 kbh Aggregate Purchase Price Associated With Land Option And Other Similar Contracts
AggregatePurchasePriceAssociatedWithLandOptionAndOtherSimilarContracts
2120000000 usd
us-gaap Applicability And Impact Of Environmental Laws
ApplicabilityAndImpactOfEnvironmentalLaws
Pursuant to SEC rules, we will disclose any proceeding in which a governmental authority is a party and that arises under any federal, state or local provisions enacted or adopted regulating the discharge of materials into the environment or primarily for the purpose of protecting the environment only where we believe that such proceeding will result in monetary sanctions on us, exclusive of interest and costs, above $1.0 million or is otherwise material to our consolidated financial statements
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
3460697 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
250000000.0 usd
CY2024Q2 kbh Increase In Common Stock Dividends Per Share Declared
IncreaseInCommonStockDividendsPerShareDeclared
0.05
CY2024Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
493641 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1109567 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.05
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
15.50
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
615926 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.05
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33400000 usd
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
33400000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
375693000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
612397000 usd
kbh Interest Paid Net Of Capitalized Amount
InterestPaidNetOfCapitalizedAmount
11999000 usd
kbh Interest Paid Net Of Capitalized Amount
InterestPaidNetOfCapitalizedAmount
12366000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
145915000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
104799000 usd
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
3149000 usd
us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
2891000 usd
kbh Increase Decrease In Consolidated Inventories Not Owned
IncreaseDecreaseInConsolidatedInventoriesNotOwned
4616000 usd
kbh Increase Decrease In Consolidated Inventories Not Owned
IncreaseDecreaseInConsolidatedInventoriesNotOwned
-2129000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000795266-24-000119-index-headers.html Edgar Link pending
0000795266-24-000119-index.html Edgar Link pending
0000795266-24-000119.txt Edgar Link pending
0000795266-24-000119-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kbh-08312024xexhibitx311.htm Edgar Link pending
kbh-08312024xexhibitx312.htm Edgar Link pending
kbh-08312024xexhibitx321.htm Edgar Link pending
kbh-08312024xexhibitx322.htm Edgar Link pending
kbh-20240831.htm Edgar Link pending
kbh-20240831.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
kbh-20240831_def.xml Edgar Link unprocessable
kbh-20240831_lab.xml Edgar Link unprocessable
kbh-20240831_pre.xml Edgar Link unprocessable
kbh-20240831_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kbh-20240831_cal.xml Edgar Link unprocessable